跳轉至內容
Merck
全部照片(1)

重要文件

EMU044851

Sigma-Aldrich

MISSION® esiRNA

targeting mouse Arhgap24

登入查看組織和合約定價
全部照片(1)

About This Item

分類程式碼代碼:
41105324
NACRES:
NA.51

描述

Powered by Eupheria Biotech

品質等級

100

產品線

MISSION®

形狀

lyophilized powder

esiRNA cDNA 標靶序列

ACAGCGGAATTTGACTTTGGAAACGGAAATGCTGAGCCTCCATGACGAACTGGATCAAGAGAGGAAAAAGTTCACCATGATAGAAATCAAGATGAGAAACGCTGAGCGCGCAAAGGAGGATGCGGAGAAAAGGAACGACATGCTCCAGAAGGAGATGGAGCAGTTCTTCTCCACATTTGGAGACCTGACAGTGGAACCCAGGAGAAGCGAGAGAGGAAACACAATCTGGATCCAGTGAGCCTTTCTCTGTCCTGGACCGCTCGCTCCGCGGAGGACTCTGGGGACTCCGGGGCAAACAGTGTTGGGGAACAGGTGTGGGATCAGGTGGTTGGTCTGTGTAGAGCTTCATCTGGTGCAGGAATCTCATTTCCAGACATCACTATCCATATCTGCAGTGTGTACCAAAGTTATATCATGCTCCATAATGCTACTGTCAAGTGTTACAACTGGATATGTGTATAGAGAGTAGTTTCTAAGATGTCAATAAGAGTAAGAAGCATATATCTCAATGATTATTTTATTGCAAGTCCTGTATTTAAATGTCGAATCAATACTTTGTTGCAATTTAGCTTGCA

Ensembl | 小鼠類登錄號

ENSMUSG00000057315

NCBI登錄號

NP_666273

運輸包裝

ambient

儲存溫度

−20°C

基因資訊

mouse ... ARHGAP24(231532) , Arhgap24(231532)

一般說明

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

法律資訊

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

10 - Combustible liquids

閃點（°F）

Not applicable

閃點（°C）

Not applicable

從最近期的版本中選擇一個：

分析證明 (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如果您需要協助，請聯絡 客戶支援

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Flaviana Marzano et al.
Molecular biology of the cell, 26(15), 2733-2741 (2015-06-13)
The regulation of insulin-like growth factor-binding protein 3 (IGFBP3) gene expression is complex, because it can be induced by agents that both stimulate and inhibit the proliferation. The principal aim of this study was to investigate whether p73, a member
Eva Tonsing-Carter et al.
Molecular cancer therapeutics, 14(12), 2850-2863 (2015-10-24)
Triple-negative breast cancers (TNBC) are typically resistant to treatment, and strategies that build upon frontline therapy are needed. Targeting the murine double minute 2 (Mdm2) protein is an attractive approach, as Mdm2 levels are elevated in many therapy-refractive breast cancers.

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務